The Indian patent office denied a drug patent application by U.S. pharmaceutical company Abbott Laboratories for the combination of lopinavir/ritonavir over the weekend, stating that the patenting was “not an invention.” The drug combination is a protease inhibitor used as a second line regimen to treat patients with HIV, and the patent denial opens the […]